ROIV insider buying and SEC filings, explained
Roivant Sciences Ltd. · CIK 1635088
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$506.3M
Planned sales (10b5-1)
$162.8M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 28, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $36.59 ($7.3M), marked as a 10b5-1 plan trade. Holdings down 14% to 1,199,154 shares. | SEC filing Filed Oct 30, 2026, 6:29 PM ET |
| Oct 20, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $35.11 ($7.0M), marked as a 10b5-1 plan trade. Holdings down 13% to 1,399,154 shares. | SEC filing Filed Oct 22, 2026, 6:44 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Epperly Melissa B (Director) sold 17,750 shares at about $36.10 ($641K), marked as a 10b5-1 plan trade. Holdings down 54% to 14,954 shares. | SEC filing Filed Oct 5, 2026, 6:05 PM ET |
| Sep 30, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $36.62 ($7.3M), marked as a 10b5-1 plan trade. Holdings down 11% to 1,599,154 shares. | SEC filing Filed Oct 2, 2026, 5:37 PM ET |
| Sep 15, 2026 | Planned (10b5-1) | Epperly Melissa B (Director) sold 4,938 shares at about $39.74 ($196K), marked as a 10b5-1 plan trade. Holdings down 33% to 9,900 shares. | SEC filing Filed Sep 17, 2026 |
| Sep 15, 2026 | Planned (10b5-1) | Meghan Fitzgerald (Director) sold 5,112 shares at about $39.74 ($203K), marked as a 10b5-1 plan trade. Holdings down 12% to 36,108 shares. | SEC filing Filed Sep 17, 2026 |
| Sep 8, 2026 | Planned (10b5-1) | Meghan Fitzgerald (Director) sold 20,000 shares at about $39.90 ($798K), marked as a 10b5-1 plan trade. Holdings down 32% to 42,963 shares. | SEC filing Filed Sep 10, 2026 |
| Aug 28, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $35.77 ($7.2M), marked as a 10b5-1 plan trade. Holdings down 11% to 1,599,154 shares. | SEC filing Filed Sep 1, 2026 |
| Jul 27, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $34.95 ($7.0M), marked as a 10b5-1 plan trade. Holdings down 11% to 1,613,063 shares. | SEC filing Filed Jul 29, 2026 |
| Jun 30, 2026 | Planned (10b5-1) | Meghan Fitzgerald (Director) sold 10,000 shares at $34.90 ($349K), marked as a 10b5-1 plan trade. Holdings down 19% to 42,963 shares. | SEC filing Filed Jul 2, 2026 |
| Jun 29, 2026 | Planned (10b5-1) | Epperly Melissa B (Director) sold 17,750 shares at about $34.38 ($610K), marked as a 10b5-1 plan trade. Holdings down 52% to 16,474 shares. | SEC filing Filed Jul 1, 2026 |
| Jun 26–30, 2026 | Sale | Keith S. Manchester (Director) sold 1,638,163 shares directly and indirectly between Jun 26 and Jun 30 at about $34.46 ($56.4M). Direct holdings down 10% to 1,748,403 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 30, 2026 |
| Jun 26–30, 2026 | Sale | Daniel Allen Gold (Director) sold 1,438,163 shares indirectly between Jun 26 and Jun 30 at about $34.32 ($49.4M). Indirect holdings down 10% to 13,689,166 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 30, 2026 |
| Jun 26–30, 2026 | Sale | QVT Financial LP (Director by Deputization) sold 1,438,163 shares indirectly between Jun 26 and Jun 30 at about $34.32 ($49.4M). Indirect holdings down 10% to 13,689,166 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 30, 2026 |
| Jun 24, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $33.16 ($6.6M), marked as a 10b5-1 plan trade. Holdings down 11% to 1,613,063 shares. | SEC filing Filed Jun 26, 2026 |
| May 22, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $30.27 ($6.1M), marked as a 10b5-1 plan trade. Holdings down 11% to 1,613,063 shares. | SEC filing Filed May 22, 2026 |
| Apr 20, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $29.59 ($5.9M), marked as a 10b5-1 plan trade. Holdings down 11% to 1,647,546 shares. | SEC filing Filed Apr 22, 2026 |
| Apr 16, 2026 | Sale | Matthew Gline (CEO and Director) sold 289,774 shares at about $29.16 ($8.4M). Holdings down 2% to 16,736,116 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 20, 2026 |
| Apr 8, 2026 | Sale | Jennifer Humes (Chief Accounting Officer) sold 13,538 shares at about $28.37 ($384K). Holdings down 14% to 84,191 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 10, 2026 |
| Mar 17, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $28.24 ($5.6M), marked as a 10b5-1 plan trade. Holdings down 11% to 1,647,546 shares. | SEC filing Filed Mar 19, 2026 |
| Mar 16, 2026 | Sale | Epperly Melissa B (Director) sold 41,861 shares at about $28.68 ($1.2M). Holdings down 73% to 15,804 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 18, 2026 |
| Feb 19–23, 2026 | Planned (10b5-1) | Frank Torti (Chair) sold 3,000,000 shares between Feb 19 and Feb 23 at about $27.35 ($82.0M), marked as a 10b5-1 plan trade. Holdings down 18% to 13,736,547 shares. | SEC filing Filed Feb 23, 2026 |
| Feb 13, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $26.49 ($5.3M), marked as a 10b5-1 plan trade. Holdings down 11% to 1,654,597 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 11–13, 2026 | Sale | Keith S. Manchester (Director) sold 1,225,784 shares indirectly between Feb 11 and Feb 13 at about $26.64 ($32.7M). Indirect holdings down 7% to 15,127,329 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 13, 2026 |
| Feb 11–13, 2026 | Sale | Daniel Allen Gold (Director) sold 1,225,784 shares indirectly between Feb 11 and Feb 13 at about $26.64 ($32.7M). Indirect holdings down 7% to 15,127,329 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 13, 2026 |
| Feb 11–13, 2026 | Sale | QVT Financial LP (Director by Deputization) sold 1,225,784 shares indirectly between Feb 11 and Feb 13 at about $26.64 ($32.7M). Indirect holdings down 7% to 15,127,329 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $21.92 ($4.4M), marked as a 10b5-1 plan trade. Holdings down 11% to 1,654,597 shares. | SEC filing Filed Jan 14, 2026 |
| Dec 23, 2025 | Sale | Richard Pulik (CFO) sold 406,731 shares at about $22.43 ($9.1M). Holdings down 63% to 239,413 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 29, 2025 |
| Dec 16–17, 2025 | Sale | Daniel Allen Gold (Director) sold 1,694,614 shares indirectly between Dec 16, 2025 and Dec 17, 2025 at about $23.05 ($39.1M). Indirect holdings down 9% to 16,353,113 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 16–17, 2025 | Sale | Keith S. Manchester (Director) sold 1,694,614 shares indirectly between Dec 16, 2025 and Dec 17, 2025 at about $23.05 ($39.1M). Indirect holdings down 9% to 16,353,113 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 16–17, 2025 | Sale | QVT Financial LP (Director by Deputization) sold 1,694,614 shares indirectly between Dec 16, 2025 and Dec 17, 2025 at about $23.05 ($39.1M). Indirect holdings down 9% to 16,353,113 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 9, 2025 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $20.85 ($4.2M), marked as a 10b5-1 plan trade. Holdings down 12% to 1,497,908 shares. | SEC filing Filed Dec 11, 2025 |
| Nov 19, 2025 | Sale | Keith S. Manchester (Director) sold 1,300,000 shares indirectly at about $20.23 ($26.3M). Indirect holdings down 7% to 18,047,727 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 21, 2025 |
| Nov 19, 2025 | Sale | Daniel Allen Gold (Director) sold 1,300,000 shares indirectly at about $20.23 ($26.3M). Indirect holdings down 7% to 18,047,727 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 21, 2025 |
| Nov 19, 2025 | Sale | QVT Financial LP (Director by Deputization) sold 1,300,000 shares indirectly at about $20.23 ($26.3M). Indirect holdings down 7% to 18,047,727 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 21, 2025 |
| Nov 13–17, 2025 | Sale | Vivek Ramaswamy (10% owner) sold 1,854,603 shares between Nov 13, 2025 and Nov 17, 2025 at about $20.46 ($37.9M). Holdings down 5% to 33,653,756 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 17, 2025 |
| Nov 7, 2025 | Planned (10b5-1) | Eric Venker (CEO) sold 200,000 shares at about $20.22 ($4.0M), marked as a 10b5-1 plan trade. Holdings down 12% to 1,504,959 shares. | SEC filing Filed Nov 7, 2025 |
88 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ROIV in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.